The NHS is grappling with a surge in patients returning from private ADHD assessments, causing a backlog in waiting lists and straining resources. This issue is exacerbated by the NHS's overspending on ADHD services, which is partially attributed to the growing reliance on poorly regulated private assessments. As awareness of ADHD increases, so does the demand for assessments, leading to over 500,000 people waiting for an evaluation. The NHS is responding by paying private providers to conduct assessments and, in some cases, prescribe medication through shared-care agreements. However, this system is fragmented and lacks clear clinical standards, leading to concerns about the quality of care and the risk of treatment gaps. The MPFT, in a letter to a patient whose shared care agreement was abruptly terminated, highlighted the challenges of the 'right to choose' pathway for ADHD services, emphasizing the limited regulation of private providers and the potential for non-compliance with NICE guidelines. This situation underscores the need for better oversight and coordination in the ADHD assessment and treatment process.
